Mikiko Matsuo

454 citations
15 papers · 310 indexed · h-index 6
Topics
Galectins and Cancer Biology (3 papers)Peptidase Inhibition and Analysis (2 papers)Macrophage Migration Inhibitory Factor (2 papers)
Partner nations
JapanPhilippinesMalawi

In The Last Decade

Mikiko Matsuo

13 papers receiving 296 citations

Peers

Mikiko Matsuo
Comparison fields: 5 of 71
  • Immunology 134
  • Molecular Biology 98
  • Oncology 57
  • Cardiology and Cardiovascular Medicine 39
  • Surgery 38
Replace Sharon O’Byrne with:
Sharon O’Byrne United Kingdom
Mara Oliveri Italy
Masakatsu Yanagimachi Japan
Andrew Soh China
Kathryn Hally New Zealand
Núria Amézaga Spain
Rundk Hwaiz Sweden
Yael Aschner United States
Donald Ruhrmund China
Mikiko Matsuo relative to Sharon O’Byrne United Kingdom Sharon O’Byrne's profile →
Citations per field
00.5×2.5×
Sharon O’Byrne · 1×
Citations per year

Countries citing papers authored by Mikiko Matsuo

Since Specialization
Citations

This map shows the geographic impact of Mikiko Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikiko Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikiko Matsuo more than expected).

Fields of papers citing papers by Mikiko Matsuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikiko Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikiko Matsuo. The network helps show where Mikiko Matsuo may publish in the future.

Co-authorship network of co-authors of Mikiko Matsuo

This figure shows the co-authorship network connecting the top 25 collaborators of Mikiko Matsuo. A scholar is included among the top collaborators of Mikiko Matsuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikiko Matsuo. Mikiko Matsuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 3
2 2
3 5
4 4
5 1
6 0
7 6
8 12
9 1
10 39
11 64
12 0
13 139
14 3
15 31

About Mikiko Matsuo

Mikiko Matsuo is a scholar working on Oncology, Critical Care and Intensive Care Medicine and Gastroenterology, having authored 15 papers that have together received 310 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (3 papers), Peptidase Inhibition and Analysis (2 papers) and Macrophage Migration Inhibitory Factor (2 papers). The work is most often cited by research in Immunology (134 citations), Oncology (57 citations) and Cardiology and Cardiovascular Medicine (39 citations). Mikiko Matsuo has collaborated with scholars based in Japan, Philippines and Malawi. Frequent co-authors include Akira Hara, Yuichiro Hatano, Hiroyuki Tomita, Kei Noguchi, Tomohiro Kanayama, Ayumi Niwa, Masayuki Niwa, Hideshi Okada, Takahiro Kuroda and Miho Takechi. Their work appears in journals such as PLoS ONE, American Journal Of Pathology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026